Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.

Chua CYX, Jain P, Ballerini A, Bruno G, Hood RL, Gupte M, Gao S, Di Trani N, Susnjar A, Shelton K, Bushman LR, Folci M, Filgueira CS, Marzinke MA, Anderson PL, Hu M, Nehete P, Arduino RC, Sastry JK, Grattoni A.

J Control Release. 2018 Sep 28;286:315-325. doi: 10.1016/j.jconrel.2018.08.010. Epub 2018 Aug 6.

PMID:
30092254
2.

HIV Care Initiation: A Teachable Moment for Smoking Cessation?

Vidrine DJ, Frank SG, Savin MJ, Waters AJ, Li Y, Chen S, Fletcher FE, Arduino RC, Gritz ER.

Nicotine Tob Res. 2018 Aug 14;20(9):1109-1116. doi: 10.1093/ntr/ntx218.

3.

Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.

Zhuang Y, Qiu X, Wang L, Ma Q, Mapstone M, Luque A, Weber M, Tivarus M, Miller E, Arduino RC, Zhong J, Schifitto G.

J Neurovirol. 2017 Oct;23(5):704-712. doi: 10.1007/s13365-017-0553-9. Epub 2017 Aug 8.

4.

The role of pain in quitting among human immunodeficiency virus (HIV)-positive smokers enrolled in a smoking cessation trial.

Aigner CJ, Gritz ER, Tamí-Maury I, Baum GP, Arduino RC, Vidrine DJ.

Subst Abus. 2017 Jul-Sep;38(3):249-252. doi: 10.1080/08897077.2017.1291466. Epub 2017 Feb 8.

5.

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN.

EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26.

6.

Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.

Sunil M, Nigalye M, Somasunderam A, Martinez ML, Yu X, Arduino RC, Utay NS, Bell TK.

AIDS Res Hum Retroviruses. 2016 Dec;32(12):1205-1209. Epub 2016 Jul 26.

7.

The role of BMI change on smoking abstinence in a sample of HIV-infected smokers.

Buchberg MK, Gritz ER, Kypriotakis G, Arduino RC, Vidrine DJ.

AIDS Care. 2016;28(5):603-7. doi: 10.1080/09540121.2015.1120854. Epub 2015 Dec 15.

8.

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.

French MA, Cozzi-Lepri A, Arduino RC, Johnson M, Achhra AC, Landay A; INSIGHT SMART Study Group.

AIDS. 2015 Apr 24;29(7):847-51. doi: 10.1097/QAD.0000000000000618.

9.

Mediators of a smoking cessation intervention for persons living with HIV/AIDS.

Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tamí-Maury I, Gritz ER.

Drug Alcohol Depend. 2015 Feb 1;147:76-80. doi: 10.1016/j.drugalcdep.2014.12.003. Epub 2014 Dec 15.

10.

Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.

Fletcher FE, Buchberg M, Schover LR, Basen-Engquist K, Kempf MC, Arduino RC, Vidrine DJ.

AIDS Care. 2014;26(10):1229-35. doi: 10.1080/09540121.2014.894617. Epub 2014 Mar 18.

11.

The influence of HIV disease events/stages on smoking attitudes and behaviors: project STATE (Study of Tobacco Attitudes and Teachable Events).

Vidrine DJ, Fletcher FE, Buchberg MK, Li Y, Arduino RC, Gritz ER.

BMC Public Health. 2014 Feb 11;14:149. doi: 10.1186/1471-2458-14-149.

12.

Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS.

Gritz ER, Danysh HE, Fletcher FE, Tami-Maury I, Fingeret MC, King RM, Arduino RC, Vidrine DJ.

Clin Infect Dis. 2013 Aug;57(4):608-15. doi: 10.1093/cid/cit349. Epub 2013 May 23.

13.

Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic.

Fletcher FE, Vidrine DJ, Tami-Maury I, Danysh HE, King RM, Buchberg M, Arduino RC, Gritz ER.

AIDS Behav. 2014 Mar;18(3):544-54. doi: 10.1007/s10461-013-0480-6.

14.

Toscana meningoencephalitis: a comparison to other viral central nervous system infections.

Jaijakul S, Arias CA, Hossain M, Arduino RC, Wootton SH, Hasbun R.

J Clin Virol. 2012 Nov;55(3):204-8. doi: 10.1016/j.jcv.2012.07.007. Epub 2012 Aug 4.

15.

Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers.

King RM, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, Gritz ER.

AIDS Patient Care STDS. 2012 Aug;26(8):479-85. doi: 10.1089/apc.2012.0070. Epub 2012 May 21.

16.

Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.

Gingaras C, Danielson BP, Vigil KJ, Vey E, Arduino RC, Kimata JT.

PLoS One. 2012;7(2):e31398. doi: 10.1371/journal.pone.0031398. Epub 2012 Feb 13.

17.

Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes.

Vidrine DJ, Marks RM, Arduino RC, Gritz ER.

Nicotine Tob Res. 2012 Jan;14(1):106-10. doi: 10.1093/ntr/ntr121. Epub 2011 Jun 13.

18.

Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels.

Arora R, Bull L, Siwak EB, Thippeshappa R, Arduino RC, Kimata JT.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):115-21. doi: 10.1097/QAI.0b013e3181daaf98.

19.

The association between body image and smoking cessation among individuals living with HIV/AIDS.

Fingeret MC, Vidrine DJ, Arduino RC, Gritz ER.

Body Image. 2007 Jun;4(2):201-6. Epub 2007 Feb 26.

20.

The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS.

Vidrine DJ, Arduino RC, Gritz ER.

AIDS Patient Care STDS. 2007 Sep;21(9):659-66.

PMID:
17919093
21.

Fosamprenavir calcium plus ritonavir for HIV infection.

Torres HA, Arduino RC.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):349-63. Review.

PMID:
17547501
22.

Alopecia associated with ritonavir-boosted atazanavir therapy.

Torres HA, Barnett BJ, Arduino RC.

AIDS. 2007 Jun 19;21(10):1391-2. No abstract available.

PMID:
17545728
23.

Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.

Torres HA, Bull L, Arduino RC, Barnett BJ.

Am J Gastroenterol. 2007 Jun;102(6):1334-5. No abstract available.

PMID:
17531028
24.

Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS.

Vidrine DJ, Arduino RC, Gritz ER.

Nicotine Tob Res. 2006 Dec;8 Suppl 1:S103-8.

PMID:
17491177
25.

Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency.

Torres HA, Barnett BJ, Arduino RC.

Clin Infect Dis. 2007 Mar 15;44(6):887-8. No abstract available.

PMID:
17304468
26.

CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV.

Lewis DE, Gross KL, Diez MM, Martinez ML, Lukefahr HN, Kozinetz CA, Arduino RC.

J Transl Med. 2007 Jan 30;5:9.

27.

CD4+ count-guided interruption of antiretroviral treatment.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C.

N Engl J Med. 2006 Nov 30;355(22):2283-96.

28.
29.

Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes.

Liu H, Dow EC, Arora R, Kimata JT, Bull LM, Arduino RC, Rice AP.

J Virol. 2006 Aug;80(15):7765-8.

30.

A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS.

Vidrine DJ, Arduino RC, Lazev AB, Gritz ER.

AIDS. 2006 Jan 9;20(2):253-60.

PMID:
16511419
31.

Assessing a conceptual framework of health-related quality of life in a HIV/AIDS population.

Vidrine DJ, Amick BC 3rd, Gritz ER, Arduino RC.

Qual Life Res. 2005 May;14(4):923-33.

PMID:
16041890
32.

CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies.

Arduino RC, Nannini EC, Rodriguez-Barradas M, Schrader S, Losso M, Ruxrungtham K, Allende MC, Emery S, Fosdick L, Neaton J, Tavel JA, Davey RT, Lane HC; Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT) Vanguard Group; ESPRIT Executive Committee.

Clin Infect Dis. 2004 Jul 1;39(1):115-22. Epub 2004 Jun 14.

PMID:
15206062
33.

Smoking behavior in a low-income multiethnic HIV/AIDS population.

Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC.

Nicotine Tob Res. 2004 Feb;6(1):71-7.

PMID:
14982690
34.

Validity of the Household and Leisure Time Activities questionnaire (HLTA) in a multiethnic HIV-positive population.

Vidrine DJ, Amick BC 3rd, Gritz ER, Arduino RC.

AIDS Care. 2004 Feb;16(2):187-97.

PMID:
14676025
35.

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.

Tedaldi EM, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, Jenny-Avital ER, McGowan JP, Perez G; Terry Beirn Community Programs for Clinical Research on AIDS.

Clin Infect Dis. 2003 May 15;36(10):1313-7. Epub 2003 May 6.

PMID:
12746778
36.

Functional status and overall quality of life in a multiethnic HIV-positive population.

Vidrine DJ, Amick BC 3rd, Gritz ER, Arduino RC.

AIDS Patient Care STDS. 2003 Apr;17(4):187-97.

PMID:
12737642
37.

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.

Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM.

AIDS. 2003 Mar 28;17(5):691-8.

PMID:
12646792
38.

Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic.

Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, Lahart CJ, Visnegarwala F.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):399-405.

PMID:
12640198
39.

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A.

AIDS Res Hum Retroviruses. 2002 Jul 1;18(10):685-93. Erratum in: AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):83..

PMID:
12167274
40.

Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas.

Nannini EC, Han X, O'Brien WA, Arduino RC.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):317-9. No abstract available.

PMID:
11873085
41.

Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.

Rakita RM, Quan VC, Jacques-Palaz K, Singh KV, Arduino RC, Mee M, Murray BE.

FEMS Immunol Med Microbiol. 2000 Aug;28(4):291-9.

42.

Syphilitic meningomyelitis treated with ceftriaxone: case report.

Gentile JH, Viviani C, Sparo MD, Arduino RC.

Clin Infect Dis. 1998 Feb;26(2):528. No abstract available.

PMID:
9502500
43.

First report of vancomycin-resistant Enterococcus faecium isolated in Argentina.

Marín ME, Mera JR, Arduino RC, Correa AP, Coque TM, Stamboulian D, Murray BE.

Clin Infect Dis. 1998 Jan;26(1):235-6. No abstract available.

PMID:
9455570
44.

Serological investigation of enterococcal infections using western blot.

Sulaiman A, Rakita RM, Arduino RC, Patterson JE, Steckelberg JM, Singh KV, Murray BE.

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):826-9.

PMID:
8950564
45.

High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci.

Coque TM, Arduino RC, Murray BE.

Clin Infect Dis. 1995 Apr;20(4):1048-51.

PMID:
7795049
46.

Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Arduino RC, Jacques-Palaz K, Murray BE, Rakita RM.

Infect Immun. 1994 Dec;62(12):5587-94.

47.

In-vitro activity of OPC-17116 against bacterial enteric pathogens.

Arduino RC, Frosolono M, Murray BE.

J Antimicrob Chemother. 1994 Sep;34(3):403-7. No abstract available.

PMID:
7829414
48.

Roles of antibodies and complement in phagocytic killing of enterococci.

Arduino RC, Murray BE, Rakita RM.

Infect Immun. 1994 Mar;62(3):987-93.

49.

Travellers' diarrhoea.

Arduino RC, DuPont HL.

Baillieres Clin Gastroenterol. 1993 Jun;7(2):365-85. Review.

PMID:
8364247
50.

Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine.

Arduino RC, Johnson PC, Miranda AG.

Clin Infect Dis. 1993 Apr;16(4):505-12.

PMID:
8513056

Supplemental Content

Loading ...
Support Center